Overview

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of neomycin on the pharmacokinetics (PK) of regorafenib in healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Neomycin